Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Citigroup
C
|
+$374M |
| 3 |
Amazon
AMZN
|
+$352M |
| 4 |
XL
XL Group Ltd.
XL
|
+$284M |
| 5 |
PPG Industries
PPG
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$288M |
| 2 |
Union Pacific
UNP
|
+$283M |
| 3 |
JPMorgan Chase
JPM
|
+$238M |
| 4 |
AGN
Allergan plc
AGN
|
+$226M |
| 5 |
Archer Daniels Midland
ADM
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 8.85% |
| 2 | Financials | 7.52% |
| 3 | Industrials | 6.64% |
| 4 | Energy | 5.78% |
| 5 | Technology | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
iShares Core MSCI EAFE ETF
IEFA
$196B
| $3.11M | ﹤0.01% |
+56,140
| New | +$3.18M |
|
|
GRN
2327
CALL
DELISTED
iPath Global Carbon ETN
GRN
| $3.1M | ﹤0.01% |
92,300
+24,600
| +36% | +$203K |
|
2328
CALL
Teradyne
TER
$65.5B
| $3.1M | ﹤0.01% |
156,500
-116,400
| -43% | -$2.2M |
|
2329
Plexus
PLXS
$7.13B
| $3.1M | ﹤0.01% |
75,114
+26,933
| +56% | +$1.05M |
|
2330
LKQ Corp
LKQ
$6.43B
| $3.09M | ﹤0.01% |
110,047
+109,734
| +35,059% | +$3.06M |
|
2331
PUT
Aptiv
APTV
$10.3B
| $3.09M | ﹤0.01% |
42,500
-17,900
| -30% | -$1.23M |
|
2332
Sinclair Inc
SBGI
$1.07B
| $3.08M | ﹤0.01% |
112,747
-251,008
| -69% | -$6.84M |
|
2333
Silicon Laboratories
SLAB
$7.29B
| $3.08M | ﹤0.01% |
64,799
-71,003
| -52% | -$3.13M |
|
|
LL
2334
PUT
DELISTED
LL Flooring Holdings, Inc.
LL
| $3.08M | ﹤0.01% |
46,500
-10,100
| -18% | -$585K |
|
2335
iShares Morningstar Mid-Cap ETF
IMCB
$1.73B
| $3.08M | ﹤0.01% |
+83,588
| New | +$2.98M |
|
2336
Bruker
BRKR
$8.79B
| $3.08M | ﹤0.01% |
156,980
+45,752
| +41% | +$880K |
|
|
LO
2337
PUT
DELISTED
LORILLARD INC COM STK
LO
| $3.08M | ﹤0.01% |
48,900
-22,300
| -31% | -$1.38M |
|
2338
Delek US
DK
$4.01B
| $3.08M | ﹤0.01% |
112,809
-119,189
| -51% | -$3.61M |
|
2339
Banco Santander Chile
BSAC
$16.3B
| $3.07M | ﹤0.01% |
155,868
+90,215
| +137% | +$1.92M |
|
|
ETP
2340
CALL
DELISTED
Energy Transfer Partners L.p.
ETP
| $3.07M | ﹤0.01% |
47,200
-5,200
| -10% | -$332K |
|
2341
AGNC Investment
AGNC
$13B
| $3.06M | ﹤0.01% |
140,307
-163,875
| -54% | -$3.7M |
|
|
BLUE
2342
PUT
DELISTED
bluebird bio
BLUE
| $3.06M | ﹤0.01% |
2,578
+1,551
| +151% | +$1.04M |
|
|
EVRI
2343
DELISTED
Everi Holdings
EVRI
| $3.06M | ﹤0.01% |
428,103
+94,541
| +28% | +$665K |
|
|
CVT
2344
DELISTED
CVENT, INC.
CVT
| $3.06M | ﹤0.01% |
109,888
+53,304
| +94% | +$1.4M |
|
2345
CALL
MannKind Corp
MNKD
$1.24B
| $3.06M | ﹤0.01% |
117,280
+1,720
| +1% | +$48.6K |
|
2346
PUT
Weyerhaeuser
WY
$17.7B
| $3.06M | ﹤0.01% |
85,200
-76,200
| -47% | -$2.62M |
|
2347
Nucor
NUE
$61B
| $3.06M | ﹤0.01% |
62,289
-164,279
| -73% | -$8.55M |
|
2348
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.32B
| $3.05M | ﹤0.01% |
+26,370
| New | +$3.13M |
|
2349
GSK
GSK
$99.2B
| $3.05M | ﹤0.01% |
57,146
-369,777
| -87% | -$20.7M |
|
2350
PUT
Analog Devices
ADI
$190B
| $3.05M | ﹤0.01% |
54,900
+22,300
| +68% | +$1.14M |
|
Similar funds
Ken Griffin's Q4 2014 Portfolio in Review
As of Q4 2014, Ken Griffin held 9,167 positions worth $102B, up 6.5% from $95.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ken Griffin's Q4 2014 filing shows 1,076 new, 3,582 increased, 3,580 reduced and 702 closed positions. Its largest new stake was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $288M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 8.8% of assets, up from 7.6% a quarter earlier, followed by Financials and Industrials.
- Ken Griffin's largest Q4 2014 buy was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.04B increase.
- Ken Griffin's biggest Q4 2014 reduction was Union Pacific, cutting an estimated $283M.
- Ken Griffin fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, selling an estimated $288M.
- Ken Griffin's ten largest holdings make up 16% of its $102B portfolio in Q4 2014.
- Ken Griffin opened 1,076 new positions and closed 702 in Q4 2014.
- Ken Griffin's portfolio value rose 6.5% quarter-over-quarter to $102B.
Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.